Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We aimed to evaluate the prognostic value of preoperative plasma
osteopontin
(
OPN
) levels in 101 patients with
hepatocellular carcinoma
(
HCC
) who underwent liver resection. Plasma
OPN
levels were detected by ELISA. The association of plasma
OPN
levels of patients with clinicopathological characteristics, tumor recurrence, and survival was analyzed. The median plasma
OPN
level of patients was 176.90 ng/ml (range 13.73-780.00 ng/ml), which was significantly higher than that of 24 healthy volunteers (63.74 ng/ml, range 12.20-122.32 ng/ml). Plasma
OPN
levels were significantly different in patients with different numbers of tumor nodules (168.18 and 217.11 ng/ml for single and multiple nodules, respectively; P = 0.002), different Edmondson's grades (201.24, 168.36, and 503.58 ng/ml for grades I, II, and III/IV, respectively; P = 0.015), and different TNM stages (168.16, 167.54, and 216.18 ng/ml for stages I, II, and III/IV, respectively; P = 0.016). Significantly higher plasma
OPN
levels were found in patients with a recurrence of
HCC
after resection, compared with those without recurrence (213.55 versus 153.70 ng/ml; P = 0.0013). A higher plasma
OPN
level was a leading independent prognostic factor for both overall survival (OS) and disease-free survival (DFS) in univariate and multivariate Cox models. This suggests that the preoperative plasma
OPN
level can be used as a predictive marker for
HCC
recurrence and may be helpful to assess the prognosis of patients with
HCC
after surgery.
...
PMID:The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. 1678 57
Hepatitis C virus (HCV) Core protein is implicated in the development of
hepatocellular carcinoma
(
HCC
). We utilized a HepG2 human hepatocyte cell line with inducible expression of HCV Core protein (HCV-1b) to investigate the early effects of Core protein on hepatocyte gene expression and to identify molecular processes modulated by the Core protein. A significant change was observed in the expression of 407 genes, which included genes regulating apoptosis, immune response, and cell cycle. Some of these genes were previously known to be tumor markers. The decreased expression of chemo-attractants such as TNFSF10, CCL20, and
osteopontin
was observed, which suggested that HCV Core expression could lead to suppression of inflammatory response as well as trafficking of macrophages and neutrophils to the site of HCV infection. An increased expression of anti-apoptosis factors including PAK2, API5, BH1, Tax1BP1, DAXX, and TNFAIP3/A20 was observed. Some of these genes were also linked to the regulation of NFKB activation and that the alteration of their expression levels, by HCV Core, might lead to the suppression NFKB activation of inflammatory responses. Our data suggested that Core expression may contribute to the viral persistence by protecting infected hepatocytes from cell death by the suppressing apoptosis and inflammatory reaction to HCV viral infection.
...
PMID:Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. 1687 23
Secreted proteins, which may be involved in the regulation of various biological processes, are the potential targets for diagnosis and treatment of diverse diseases. In this study, to identify the human
hepatoma
HepG2 cells-derived secreted proteins more extensively, we applied the protein sample preparations using the combinations of denaturation methods and molecular-mass cutoff via ultrafiltration to the two-dimensional liquid chromatography coupled with tandem mass spectrometry (2D LC-MS/MS) analysis. We were able to identify a total of 86 proteins containing widely known secreted proteins of HepG2 such as alpha-fetoprotein, of which 73 proteins including 27 signal peptide-containing proteins have never been reported to be secreted from HepG2 cells in other proteomic studies. Among the identified signal peptide-containing proteins, ten proteins such as growth differentiation factor 15,
osteopontin
and stanniocalcin 2 were discovered as new secreted proteins of HepG2 cells. These observations suggest that the combinations of different sample preparation methods and 2D LC-MS/MS analysis are useful for identifying a wider range of low-abundance proteins and that the secreted proteins from HepG2 identified in this study may be useful as liver-specific biomarkers for diagnosis and treatment.
...
PMID:Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry. 1710 77
Tumour-associated trypsin inhibitor (TATI) overexpresses in various tumours, but its clinicopathological significance in
hepatocellular carcinoma
(
HCC
) is unclear. Differential display analysis revealed expression of TATI in
HCC
. By RT-PCR in the linear range, TATI was found to be overexpressed in 176 of 258 unifocal primary HCCs (68%). TATI overexpression correlated with high-stage
HCC
(stage IIIB to IV) with portal vein (PV) invasion (p=0.00014), early tumour recurrence (ETR; p=0.00002), and a lower 5-year survival (p=0.000001), in both low- and high-stage
HCC
(p=0.033 and p=0.00036, respectively). Ectopic expression of TATI led to enhanced anchorage-independent tumour cell growth in vitro. To determine its potential as a part of a group of combined diagnostic markers, we analysed 235 HCCs for three genes encoding secretory proteins known to be overexpressed in
HCC
; these were TATI, AFP and
osteopontin
; 202 of the tumours (86%) overexpressed one or more of these genes. Further,
HCC
with a greater number of gene overexpressions produced bigger tumours (p=0.0024), had a higher rate of PV invasion (p= 1x10(-8)), had a higher ETR (p=1x10(-8)), and showed a lower 5-year survival (p=0.000001). We conclude that TATI overexpression contributes to cell growth advantage, enhances the metastatic potential of tumours and leads to advanced
HCC
with PV invasion. Thus, it is a stage-independent prognostic factor for
HCC
and a useful predictor for ETR. Moreover, it should be possible to use TATI, AFP and
osteopontin
as combined markers for molecular staging, the detection of
HCC
and for the prediction of ETR.
...
PMID:Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. 1726 2
Tumor cell invasion is a primary event in the metastatic progression of
hepatocellular carcinoma
(
HCC
). Our recent results indicate a concordant elevated expression of
osteopontin
(
OPN
) and matrix metalloproteinase-9 (MMP-9) in primary metastatic
HCC
. This study hypothesizes an MMP-9-directed cleavage of
OPN
that biologically contributes to
HCC
metastasis. We found that MMP-9 cleaved
OPN
into specific fragments in vitro, of which three could be identified by Edman degradation amino-acid sequencing. One of these fragments (OPN-5 kDa, residues 167-210) induced low-metastatic
HCC
cellular invasion via CD44 receptors, which was effectively blocked by the addition of small peptides within the region of
OPN
-5 kDa. Increased expression of an
OPN
splice variant (OPN-c) was associated with clinical metastatic
HCC
. Overexpression of OPN-c with physiological levels of MMP-9 enhanced cellular invasion and coincided with elevated
OPN
-5 kDa levels. Our data suggest that an alternative splicing event (OPN-c) promotes extracellular cleavage of
OPN
by MMP-9, thus releasing a distinct region of
OPN
(OPN-5 kDa) that is essential for
HCC
cellular invasion and appears to correlate with metastatic potential. The findings of this study may help to improve advanced-stage
HCC
prognosis and suggest the utility of small peptides for novel therapies.
...
PMID:An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. 1745 79
Increasing evidence indicates that macrophages in tumor stroma can significantly modify the malignant phenotypes of tumors.
Osteopontin
(
OPN
) is frequently overexpressed in cancers with high metastatic capacity and, thus, has been considered as a potential therapeutic target. To find out whether macrophages can affect the outcome of
OPN
-knockdown tumor cells, we used RNA interference (RNAi) to stably silence the
OPN
expression in the highly invasive human
hepatoma
cell line SK-Hep-1. Silencing of
OPN
markedly decreased the motility and invasiveness of the SK-Hep-1 cells. Further studies using this cell model revealed that coculture with human macrophages or macrophage-conditioned medium largely restored the migration and invasion potential of
OPN
-knockdown tumor cells. Moreover, such macrophage-promoted motility can be effectively blocked either by the addition of
OPN
-neutralizing antibody to the cocultured medium or by silencing
OPN
expression in macrophages. These results indicate that macrophage-derived
OPN
can compensate for the decrease of
OPN
and thereby restore the metastatic potential of
OPN
-knockdown tumor cells. Further characterization of the underlying mechanisms disclosed that macrophage-derived
OPN
exerted its function independently of the actin cytoskeleton rearrangement or the activation of matrix metalloproteinase and Rho families. Our results suggest that there are fine-tuned complex interactions between cancer cells and stroma cells, which may modify the outcome of cancer therapy, and therefore should be considered for the rational design of anticancer strategy.
...
PMID:Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells. 1754 92
Osteopontin
(
OPN
) is a highly modified integrin-binding extracellular matrix glycophosphoprotein produced by cells of the immune system, epithelial tissue, smooth muscle cells, osteoblasts, and tumor cells. Extensive research has elucidated the pivotal role of
OPN
in cell signaling that controls inflammation, tumor progression, and metastasis.
OPN
interaction with the integrin receptors expressed on inflammatory cells through its arginine-glycine-aspartate (RGD) and non-RGD motifs promote migration and adhesion of cells. In the liver, it has been reported that hepatic Kupffer cells secrete
OPN
facilitating macrophage infiltration into necrotic areas following carbon tetrachloride liver toxicity. Recent work has highlighted the role of
OPN
in inflammatory liver diseases such as alcoholic and nonalcoholic liver disease and T-cell-mediated hepatitis. The role of
OPN
in
hepatocellular carcinoma
(
HCC
) has also generated significant interest, especially with regards to its role as a prognostic factor.
OPN
therefore appears to play an important role during liver inflammation and cancer. In this review we will present data to demonstrate the key role played by
OPN
in mediating hepatic inflammation (neutrophils, monocytes/macrophages, and lymphocytes) and its role in
HCC
. Greater understanding of the pathophysiologic role of
OPN
in hepatic inflammation and cancer may enable development of novel inflammation and cancer treatment strategies.
...
PMID:Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. 1789 Jul 65
DNA microarray analysis of human cancer has resulted in considerable accumulation of global gene profiles. However, extraction and understanding the underlying biology of cancer progression remains a significant challenge. This study applied a novel integrative computational and analytical approach to this challenge in human
hepatocellular carcinoma
(
HCC
) with the aim of identifying potential molecular markers or novel therapeutic targets. We analysed 100
HCC
tissue samples by human 30K DNA microarray. The gene expression data were uploaded into the network analysis tool, and the biological networks were displayed graphically. We identified several activated 'hotspot' regions harbouring a concentration of upregulated genes. Several 'hotspot' regions revealed integrin and Akt/NF-kappaB signalling. We identified key members linked to these signalling pathways including
osteopontin
(SPP1), glypican-3 (GPC3), annexin 2 (ANXA2), S100A10 and vimentin (VIM). Our integrative approach should significantly enhance the power of microarray data in identifying novel potential targets in human cancer.
...
PMID:Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. 1833 85
The process of cell dissemination from the primary tumors to distant sites is the most harmful event during cancer progression, and the leading cause of cancer death. We have previously demonstrated that restoration of DLC1 tumor suppressor gene expression in the DLC1-negative Focus and 7703K human
hepatocellular carcinoma
(
HCC
) cell lines induced caspase-3 mediated apoptosis, reduced cell growth in vitro and tumorigenicity in vivo and diminished the ability to migrate through Matrigel, a property suggestive of metastatic potential in vivo. We now show that subcutaneous tumors developing after inoculation of Focus and 7703K cells into nude mice disseminate cells to liver and lung, and this process is markedly suppressed by restoration of DLC1 expression. Inhibition of tumor cell dissemination was associated with lower levels of RhoA activity, an increase in rounded cells and a reduction in actin stress fibers and focal adhesion molecules that are of critical importance in cancer cell invasion and metastasis. In addition, DLC1 down-regulated the expression of
osteopontin
and matrix metalloproteinase-9, which are highly up-regulated in most primary
HCC
with associated metastases. These observations implicate the DLC1 gene in suppression of
HCC
cell dissemination and identify novel cellular and genetic alterations that contribute to prevention of metastasis, a life-threatening event in cancer progression.
...
PMID:DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. 1849 90
This study retrospectively evaluated the immunohistochemical expression of 3 cell adhesion molecules (CAMs), E-cadherin, beta-catenin, and
osteopontin
, according to tumor grade in 125 surgically resected specimens of
hepatocellular carcinoma
(
HCC
). The aims of this study were to identify factors associated with vascular invasion and to elucidate the prognostic value of CAMs. The median follow-up time was 110 months. The levels of E-cadherin, beta-catenin, and
osteopontin
immunoreactivity were significantly associated with Edmondson-Steiner grade but not with tumor size. There was increased loss of E-cadherin, nonnuclear overexpression of beta-catenin, and overexpression of
osteopontin
in tumors of higher histologic grade. Vascular invasion was found in 44 (35%) of 125 resected specimens. Logistic regression analysis identified 3 tumor-related factors that were independently associated with vascular invasion-tumor size more than 3 cm, Edmondson-Steiner grades III to IV, and overexpression of
osteopontin
. Among the tested CAMs,
osteopontin
(P = .0110) and E-cadherin (P = .0287) were significant prognostic factors by univariate analysis. The Cox proportional hazard regression analysis revealed that Edmondson-Steiner grades III to IV (relative risk [RR], 3.028; P < .001), the presence of vascular invasion (RR, 1.964; P = .011), overexpression of
osteopontin
(RR, 1.755; P = .034), serum alpha-fetoprotein level more than 20 ng/mL (RR, 1.834; P = .037), and Child-Pugh classification B to C (RR, 1.880; P = .040) were found to be independently significant factors associated with survival after hepatectomy. These results suggest that overexpression of
osteopontin
independently correlates with vascular invasion and thus predicts poor survival for patients with
HCC
, whereas aberrant expression of E-cadherin or beta-catenin does not.
...
PMID:Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma. 1870 Nov 36
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>